FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

13765011000001103: Clarithromycin 250mg tablets (Apotex Europe Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
49027801000001113 Clarithromycin 250mg tablets (Apotex Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
53187501000001119 Clarithromycin 250mg tablets (Apotex UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clarithromycin 250mg tablets (Apotex Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) Is a Product containing precisely clarithromycin 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) Has active ingredient Clarithromycin false Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) Has specific active ingredient Clarithromycin true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Clarithromycin 250mg tablets (Apotex Europe Ltd) 14 tablet Is pack of False Clarithromycin 250mg tablets (Apotex Europe Ltd) Inferred relationship Existential restriction modifier
Clarithromycin 250mg tablets (Apotex Europe Ltd) 14 tablet Has AMP True Clarithromycin 250mg tablets (Apotex Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start